Judgement bias mitigation minimises subjective assessment distortions in clinical interpretation. Blinding prevents outcome knowledge influencing assessments. Standardised assessment criteria reduce investigator variation. Objective biomarkers replace subjective endpoints. Central assessment committees provide expert review.
Training programmes enhance assessment consistency. Quality control monitoring detects assessment variability. Regulatory expectations emphasise bias minimisation. Statistical methods account for residual bias. Emerging digital biomarkers eliminate observer bias.
General Biopharmaceutical Concepts
Judgement Bias Mitigation
Judgement bias mitigation implements structured methods to reduce subjective bias during scientific evaluation, clinical assessment and regulatory decision-making.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →